MPM BioImpact’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Hold |
2,408,810
| – | – | 0.45% | 40 |
|
|
2025
Q1 | $2.34M | Buy |
2,408,810
+20,799
| +0.9% | +$20.2K | 0.4% | 39 |
|
|
2024
Q4 | $3.53M | Hold |
2,388,011
| – | – | 0.5% | 41 |
|
|
2024
Q3 | $5.06M | Hold |
2,388,011
| – | – | 0.76% | 37 |
|
|
2024
Q2 | $5.83M | Hold |
2,388,011
| – | – | 0.91% | 36 |
|
|
2024
Q1 | $15.5M | Hold |
2,388,011
| – | – | 2.49% | 11 |
|
|
2023
Q4 | $9.22M | Hold |
2,388,011
| – | – | 2.16% | 20 |
|
|
2023
Q3 | $5.11M | Hold |
2,388,011
| – | – | 1.36% | 24 |
|
|
2023
Q2 | $7.28M | Hold |
2,388,011
| – | – | 1.47% | 21 |
|
|
2023
Q1 | $6.21M | Hold |
2,388,011
| – | – | 1.61% | 18 |
|
|
2022
Q4 | $4.9M | Hold |
2,388,011
| – | – | 1.27% | 19 |
|
|
2022
Q3 | $10.8M | Hold |
2,388,011
| – | – | 2.55% | 12 |
|
|
2022
Q2 | $9.77M | Hold |
2,388,011
| – | – | 2.71% | 10 |
|
|
2022
Q1 | $10.5M | Hold |
2,388,011
| – | – | 2.82% | 7 |
|
|
2021
Q4 | $28.4M | Hold |
2,388,011
| – | – | 5.19% | 6 |
|
|
2021
Q3 | $41M | Hold |
2,388,011
| – | – | 6.36% | 4 |
|
|
2021
Q2 | $41.6M | Buy |
+2,388,011
| New | +$41.6M | 6.84% | 6 |
|